Kwang Hee Han

Title: Innovations of Kwang Hee Han in Radiopharmaceuticals

Introduction

Kwang Hee Han is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative methods for labeling compounds with technetium and rhenium. With a total of 2 patents, his work is recognized for its potential impact on medical applications.

Latest Patents

Kwang Hee Han's latest patents include a method for labeling technetium or rhenium using borohydride exchange resin. This method allows for the direct labeling of disulfide compounds with technetium or rhenium, bypassing the need for a synthetic step involving thiol-protected S-precursors. This innovation is particularly useful for creating high value-added radiopharmaceuticals. His second patent focuses on the preparation of technetium or rhenium complexes for radiopharmaceuticals. This method utilizes a borohydride exchange resin as a reducing agent, which is stable across a wide pH range and can be easily removed through filtration. The resulting radiolabeled complex is produced under milder conditions than conventional methods, ensuring high radiochemical purity and labeling efficiency.

Career Highlights

Kwang Hee Han is affiliated with the Korea Atomic Energy Research Institute, where he continues to advance research in radiopharmaceuticals. His work is characterized by a commitment to improving the efficiency and effectiveness of radiolabeling techniques.

Collaborations

He has collaborated with notable colleagues, including Kyung Bae Park and Sang Hyun Park, who contribute to the research environment at the Korea Atomic Energy Research Institute.

Conclusion

Kwang Hee Han's innovative approaches to radiopharmaceuticals demonstrate his significant role in advancing medical technology. His patents reflect a dedication to improving the methods used in the field, which may lead to enhanced applications in healthcare.